Differentially Methylated Loci Distinguish Ovarian Carcinoma Histological Types: Evaluation of a DNA Methylation Assay in FFPE Tissue

by Linda E. Kelemen, Martin Köbel, Angela Chan, Soreh Taghaddos, Irina Dinu
Published 2013-01-01

Ovarian cancer: diagnostic accuracy and tumor types distribution in East Africa compared to North America

by Peter F. Rambau, Martin Köbel, Derek Tilley, Alex Mremi, Robert Lukande, William Muller
Published 2020-07-01

Association of Hormone Receptor Expression with Survival in Ovarian Endometrioid Carcinoma: Biological Validation and Clinical Implications

by Peter Rambau, Linda E. Kelemen, Helen Steed, May Lynn Quan, Prafull Ghatage, Martin Köbel
Published 2017-02-01

A COEUR cohort study of SATB2 expression and its prognostic value in ovarian endometrioid carcinoma

by Cécile Le Page, Martin Köbel, Liliane Meunier, Diane M Provencher, Anne‐Marie Mes‐Masson, Kurosh Rahimi
Published 2019-07-01

A Keratin 7 and E-Cadherin Signature Is Highly Predictive of Tubo-Ovarian High-Grade Serous Carcinoma Prognosis

by Laudine Communal, Noemi Roy, Maxime Cahuzac, Kurosh Rahimi, Martin Köbel, Diane M. Provencher, Anne-Marie Mes-Masson
Published 2021-05-01

Aberrantly Expressed Embryonic Protein NODAL Alters Breast Cancer Cell Susceptibility to γδ T Cell Cytotoxicity

by Gabrielle M. Siegers, Indrani Dutta, Eun Young Kang, Jing Huang, Martin Köbel, Lynne-Marie Postovit, Lynne-Marie Postovit
Published 2020-06-01

Expression of Class I Histone Deacetylases Indicates Poor Prognosis in Endometrioid Subtypes of Ovarian and Endometrial Carcinomas

by Wilko Weichert, Carsten Denkert, Aurelia Noske, Silvia Darb-Esfahani, Manfred Dietel, Steve E. Kalloger, David G. Huntsman, Martin Köbel
Published 2008-09-01

Correction: Systematic Analysis of Immune Infiltrates in High-Grade Serous Ovarian Cancer Reveals CD20, FoxP3 and TIA-1 as Positive Prognostic Factors

by Katy Milne, Martin Köbel, Steven E. Kalloger, Rebecca O. Barnes, Dongxia Gao, C. Blake Gilks, Peter H. Watson, Brad H. Nelson
Published 2013-01-01

Systematic analysis of immune infiltrates in high-grade serous ovarian cancer reveals CD20, FoxP3 and TIA-1 as positive prognostic factors.

by Katy Milne, Martin Köbel, Steven E Kalloger, Rebecca O Barnes, Dongxia Gao, C Blake Gilks, Peter H Watson, Brad H Nelson
Published 2009-01-01

Correction: Systematic Analysis of Immune Infiltrates in High-Grade Serous Ovarian Cancer Reveals CD20, FoxP3 and TIA-1 as Positive Prognostic Factors.

by Katy Milne, Martin Köbel, Steven E. Kalloger, Rebecca O. Barnes, Dongxia Gao, C. Blake Gilks, Peter H. Watson, Brad H. Nelson
Published 2013-01-01

SWI/SNF‐deficiency defines highly aggressive undifferentiated endometrial carcinoma

by Basile Tessier‐Cloutier, Mackenzie Coatham, Mark Carey, Gregg S Nelson, Sarah Hamilton, Amy Lum, Robert A Soslow, Colin JR Stewart, Lynne M Postovit, Martin Köbel, Cheng‐Han Lee
Published 2021-03-01

PODO447: a novel antibody to a tumor-restricted epitope on the cancer antigen podocalyxin

by Blake Gilks, Martin Köbel, Diana Canals Hernaez, Michael R Hughes, Pamela Dean, Peter Bergqvist, Ismael Samudio, Ola Blixt, Katharina Wiedemeyer, Yicong Li, Chris Bond, Eric Cruz, Calvin D Roskelley, Kelly M McNagny
Published 2020-07-01

Establishment and characterization of VOA1066 cells: An undifferentiated endometrial carcinoma cell line.

by Yemin Wang, Valerie Lan Tao, Chae Young Shin, Clara Salamanca, Shary Yuting Chen, Christine Chow, Martin Köbel, Susana Ben-Neriah, David Farnell, Christian Steidl, Jessica N Mcalpine, C Blake Gilks, David G Huntsman
Published 2020-01-01

Embryonic protein NODAL regulates the breast tumor microenvironment by reprogramming cancer-derived secretomes

by Dylan Dieters-Castator, Paola M. Dantonio, Matt Piaseczny, Guihua Zhang, Jiahui Liu, Miljan Kuljanin, Stephen Sherman, Michael Jewer, Katherine Quesnel, Eun Young Kang, Martin Köbel, Gabrielle M. Siegers, Andrew Leask, David Hess, Gilles Lajoie, Lynne-Marie Postovit
Published 2021-04-01

Ovarian carcinoma subtypes are different diseases: implications for biomarker studies.

by Martin Köbel, Steve E Kalloger, Niki Boyd, Steven McKinney, Erika Mehl, Chana Palmer, Samuel Leung, Nathan J Bowen, Diana N Ionescu, Ashish Rajput, Leah M Prentice, Dianne Miller, Jennifer Santos, Kenneth Swenerton, C Blake Gilks, David Huntsman
Published 2008-12-01

Overexpression of IGF2BP3 as a Potential Oncogene in Ovarian Clear Cell Carcinoma

by Huidi Liu, Huidi Liu, Huidi Liu, Huidi Liu, Huidi Liu, Zheng Zeng, Zheng Zeng, Zheng Zeng, Mitra Afsharpad, Caiji Lin, Caiji Lin, Caiji Lin, Siwen Wang, Siwen Wang, Siwen Wang, Hao Yang, Shuhong Liu, Linda E. Kelemen, Wenwen Xu, Wenwen Xu, Wenwen Xu, Wenqing Ma, Wenqing Ma, Wenqing Ma, Qian Xiang, Qian Xiang, Qian Xiang, Emilio Mastriani, Emilio Mastriani, Emilio Mastriani, Pengfei Wang, Pengfei Wang, Pengfei Wang, Jiali Wang, Jiali Wang, Jiali Wang, Shu-Lin Liu, Shu-Lin Liu, Shu-Lin Liu, Shu-Lin Liu, Randal N. Johnston, Randal N. Johnston, Martin Köbel, Martin Köbel
Published 2020-01-01

Combined CCNE1 high‐level amplification and overexpression is associated with unfavourable outcome in tubo‐ovarian high‐grade serous carcinoma

by Angela MY Chan, Emeka Enwere, John B McIntyre, Holly Wilson, Chidera Nwaroh, Nicholas Wiebe, Young Ou, Shuhong Liu, Katharina Wiedemeyer, Peter F Rambau, Xin Grevers, Donald G Morris, Paola Neri, C Blake Gilks, Frank Visser, Nhu Le, Li Luo, Linda S Cook, Martin Köbel
Published 2020-10-01

Tumor-infiltrating T cells correlate with NY-ESO-1-specific autoantibodies in ovarian cancer.

by Katy Milne, Rebecca O Barnes, Adam Girardin, Melanie A Mawer, Nancy J Nesslinger, Alvin Ng, Julie S Nielsen, Robert Sahota, Eric Tran, John R Webb, May Q Wong, Darin A Wick, Andrew Wray, Elissa McMurtrie, Martin Köbel, Steven E Kalloger, C Blake Gilks, Peter H Watson, Brad H Nelson
Published 2008-01-01

Characteristics and outcome of the COEUR Canadian validation cohort for ovarian cancer biomarkers

by Cécile Le Page, Kurosh Rahimi, Martin Köbel, Patricia N. Tonin, Liliane Meunier, Lise Portelance, Monique Bernard, Brad H. Nelson, Marcus Q. Bernardini, John M. S. Bartlett, Dimcho Bachvarov, Walter H. Gotlieb, Blake Gilks, Jessica N. McAlpine, Mark W. Nachtigal, Alain Piché, Peter H. Watson, Barbara Vanderhyden, David G. Huntsman, Diane M. Provencher, Anne-Marie Mes-Masson
Published 2018-03-01

Pleiotropy-guided transcriptome imputation from normal and tumor tissues identifies candidate susceptibility genes for breast and ovarian cancer

by Siddhartha P. Kar, Daniel P.C. Considine, Jonathan P. Tyrer, Jasmine T. Plummer, Stephanie Chen, Felipe S. Dezem, Alvaro N. Barbeira, Padma S. Rajagopal, Will T. Rosenow, Fernando Moreno, Clara Bodelon, Jenny Chang-Claude, Georgia Chenevix-Trench, Anna deFazio, Thilo Dörk, Arif B. Ekici, Ailith Ewing, George Fountzilas, Ellen L. Goode, Mikael Hartman, Florian Heitz, Peter Hillemanns, Estrid Høgdall, Claus K. Høgdall, Tomasz Huzarski, Allan Jensen, Beth Y. Karlan, Elza Khusnutdinova, Lambertus A. Kiemeney, Susanne K. Kjaer, Rüdiger Klapdor, Martin Köbel, Jingmei Li, Clemens Liebrich, Taymaa May, Håkan Olsson, Jennifer B. Permuth, Paolo Peterlongo, Paolo Radice, Susan J. Ramus, Marjorie J. Riggan, Harvey A. Risch, Emmanouil Saloustros, Jacques Simard, Lukasz M. Szafron, Linda Titus, Cheryl L. Thompson, Robert A. Vierkant, Stacey J. Winham, Wei Zheng, Jennifer A. Doherty, Andrew Berchuck, Kate Lawrenson, Hae Kyung Im, Ani W. Manichaikul, Paul D.P. Pharoah, Simon A. Gayther, Joellen M. Schildkraut
Published 2021-07-01